Gestational Diabetes: Tests, Diet and Risks

Gestational Diabetes: Tests, Diet and Risks

Gestational diabetes mellitus (GDM) is a form of diabetes that develops during pregnancy and usually resolves after childbirth. It affects 1 in 6 pregnancies worldwide and is particularly common in South Asian women. While often manageable, untreated GDM poses significant risks to both mother and baby, making early detection and proper management essential.

What Is Gestational Diabetes?

During pregnancy, the placenta produces hormones that increase insulin resistance. In most women, the pancreas compensates by producing more insulin. In GDM, the pancreas cannot keep up, leading to elevated blood sugar levels.

GDM typically develops between weeks 24-28 of pregnancy, when insulin resistance peaks. It usually resolves after delivery, but women with GDM have a 50% risk of developing type 2 diabetes within 10 years.

A 2021 study in The Lancet found that GDM prevalence varies significantly by ethnicity: 20-25% in South Asian women vs 5-8% in Caucasian women, highlighting the genetic and environmental factors at play.

Risk Factors

• Overweight or obesity (BMI ≥ 25, or ≥ 23 for Asians)
• Family history of diabetes
• Previous GDM or large baby (> 4 kg)
• Age over 35
• PCOS
• South Asian, African, or Hispanic ethnicity
• Previous unexplained stillbirth

Screening and Tests

When to screen: All pregnant women should be screened at 24-28 weeks. High-risk women should be screened at the first prenatal visit.

Screening tests:

• Glucose Challenge Test (GCT): 50g glucose, blood drawn 1 hour later. If ≥ 140 mg/dL, proceed to OGTT.
• Oral Glucose Tolerance Test (OGTT): 75g or 100g glucose, fasting + 1-hour + 2-hour blood draws. Diagnosis if fasting ≥ 92, 1-hour ≥ 180, or 2-hour ≥ 153 mg/dL (IADPSG criteria).

The IADPSG (International Association of Diabetes and Pregnancy Study Groups) criteria, adopted by most countries including India, require only one abnormal value for diagnosis.

Risks of Untreated GDM

For the baby:

• Macrosomia (large baby, > 4 kg) — increases birth injury risk
• Neonatal hypoglycemia
• Respiratory distress syndrome
• Jaundice
• Stillbirth (in severe cases)
• Increased risk of obesity and type 2 diabetes later in life

For the mother:

• Preeclampsia
• Cesarean delivery
• 50% risk of type 2 diabetes within 10 years
• Recurrence in future pregnancies (30-50%)

Management: Diet and Lifestyle

Dietary recommendations:

• Complex carbohydrates (whole grains, millets, dal) — 40-45% of calories
• Lean protein — 20-25% of calories
• Healthy fats — 30-35% of calories
• Small, frequent meals (3 meals + 2-3 snacks)
• Avoid: sugary drinks, refined carbs, excessive fruit juice
• Indian diet: Replace white rice with brown rice/millets; include dal, vegetables, and protein at every meal

Exercise: 30 minutes of moderate activity daily (walking, swimming, prenatal yoga). Exercise improves insulin sensitivity and helps control blood sugar.

Blood sugar monitoring: Check fasting and 1-hour or 2-hour post-meal glucose as advised by your doctor.

Medical Treatment

If diet and exercise alone don't control blood sugar (fasting > 95 mg/dL or post-meal > 140 mg/dL), medication is needed:

• Insulin: First-line medication for GDM (does not cross placenta)
• Metformin: Used in some cases, though insulin is preferred
• Glyburide: Alternative oral medication

Postpartum Follow-Up

• Glucose tolerance test at 6-12 weeks postpartum
• Annual diabetes screening thereafter
• Lifestyle modifications to reduce future diabetes risk
• Breastfeeding reduces risk of future type 2 diabetes

Conclusion

Gestational diabetes is common, manageable, and usually resolves after delivery. However, it requires careful monitoring and management to protect both mother and baby. Early screening, dietary modification, regular exercise, and medical treatment when needed can ensure a healthy pregnancy outcome. Women with GDM should also be screened for type 2 diabetes regularly after delivery.

References:

• International Association of Diabetes and Pregnancy Study Groups. (2010). Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 33(3), 676-682.
• American Diabetes Association. (2024). Standards of Medical Care in Diabetes. Diabetes Care, 47(Supplement_1).
• Metzger, B.E., et al. (2008). Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine, 358(19), 1991-2002.
• Crowther, C.A., et al. (2005). Effect of treatment of gestational diabetes on pregnancy outcomes. The New England Journal of Medicine, 352(24), 2477-2486.
• Anjana, R.M., et al. (2017). Prevalence of diabetes and prediabetes in 15 states of India. The Lancet Diabetes & Endocrinology, 5(8), 585-596.